AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- EBITDA, 2022
- $9.2B
- YoY, 2022
- +21.8%
- 5-year CAGR
- +6.6%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2022 | $9.2B | +21.8% |
| 2021 | $7.6B | −8.7% |
| 2020 | $8.3B | +24.3% |
| 2019 | $6.7B | −6.4% |
| 2018 | $7.1B | +6.4% |
| 2017 | $6.7B | −7.5% |
| 2016 | $7.3B | +4.2% |
| 2015 | $7.0B | — |